Clinical, pathological, and genetic features of dynamin-2-related centronuclear myopathy in China

Neurological Sciences

Volumn 36, Issue 5, 2015, Pages 735-741

  Chen, Ting ^a,b   Pu, Chuanqiang ^a,b   Wang, Qian ^c   Liu, Jiexiao ^a   Mao, Yanling ^a   Shi, Qiang ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b NANKAI UNIVERSITY   (China)

^c GENERAL HOSPITAL OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

Author keywords

Centronuclear myopathy; Clinical; Dynamin 2; Genetic analysis; Muscle biopsy

Indexed keywords

CREATINE KINASE; DYNAMIN II;

ADOLESCENT; BLOOD; CHILD; CHINA; ELECTROMYOGRAPHY; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; MUTATION; MYOPATHY; PATHOLOGY; RETROSPECTIVE STUDY; SKELETAL MUSCLE;

ADOLESCENT; CHILD; CHINA; CREATINE KINASE; DYNAMIN II; ELECTROMYOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUTATION; MYOPATHIES, STRUCTURAL, CONGENITAL; RETROSPECTIVE STUDIES;

EID: 84939985319     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-014-2028-6     Document Type: Article

References (19)

1. Zuchner S, Noureddine M, Kennerson M, Verhoeven K, Claeys K, De Jonghe P, Merory J, Oliveira SA, Speer MC, Stenger JE, Walizada G, Zhu D, Pericak-Vance MA, Nicholson G, Timmerman V, Vance JM (2005) Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat Genet 37(3):289–294. doi:10.1038/ng1514
2. Bitoun M, Maugenre S, Jeannet PY, Lacene E, Ferrer X, Laforet P, Martin JJ, Laporte J, Lochmuller H, Beggs AH, Fardeau M, Eymard B, Romero NB, Guicheney P (2005) Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet 37(11):1207–1209. doi:10.1038/ng1657
3. Majczenko K, Davidson AE, Camelo-Piragua S, Agrawal PB, Manfready RA, Li X, Joshi S, Xu J, Peng W, Beggs AH, Li JZ, Burmeister M, Dowling JJ (2012) Dominant mutation of CCDC78 in a unique congenital myopathy with prominent internal nuclei and atypical cores. Am J Hum Genet 91(2):365–371. doi:10.1016/j.ajhg.2012.06.012
4. Nicot AS, Toussaint A, Tosch V, Kretz C, Wallgren-Pettersson C, Iwarsson E, Kingston H, Garnier JM, Biancalana V, Oldfors A, Mandel JL, Laporte J (2007) Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy. Nat Genet 39(9):1134–1139. doi:10.1038/ng2086
5. Jungbluth H, Zhou H, Sewry CA, Robb S, Treves S, Bitoun M, Guicheney P, Buj-Bello A, Bonnemann C, Muntoni F (2007) Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord 17(4):338–345. doi:10.1016/j.nmd.2007.01.016
6. Tosch V, Rohde HM, Tronchere H, Zanoteli E, Monroy N, Kretz C, Dondaine N, Payrastre B, Mandel JL, Laporte J (2006) A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy. Hum Mol Genet 15(21):3098–3106. doi:10.1093/hmg/ddl250
7. Bohm J, Biancalana V, Dechene ET, Bitoun M, Pierson CR, Schaefer E, Karasoy H, Dempsey MA, Klein F, Dondaine N, Kretz C, Haumesser N, Poirson C, Toussaint A, Greenleaf RS, Barger MA, Mahoney LJ, Kang PB, Zanoteli E, Vissing J, Witting N, Echaniz-Laguna A, Wallgren-Pettersson C, Dowling J, Merlini L, Oldfors A, Bomme Ousager L, Melki J, Krause A, Jern C, Oliveira AS, Petit F, Jacquette A, Chaussenot A, Mowat D, Leheup B, Cristofano M, Poza Aldea JJ, Michel F, Furby A, Llona JE, Van Coster R, Bertini E, Urtizberea JA, Drouin-Garraud V, Beroud C, Prudhon B, Bedford M, Mathews K, Erby LA, Smith SA, Roggenbuck J, Crowe CA, Brennan Spitale A, Johal SC, Amato AA, Demmer LA, Jonas J, Darras BT, Bird TD, Laurino M, Welt SI, Trotter C, Guicheney P, Das S, Mandel JL, Beggs AH, Laporte J (2012) Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy. Hum Mutat 33(6):949–959. doi:10.1002/humu.22067
8. Fischer D, Herasse M, Bitoun M, Barragan-Campos HM, Chiras J, Laforet P, Fardeau M, Eymard B, Guicheney P, Romero NB (2006) Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy. Brain 129(Pt 6):1463–1469
9. Zhang Y, Gu W, Hao Y, Pan L, Du H, Yan L, Duan X, Sun S, Wang X (2007) Clinical, pathological and molecular biological study on a family of autosomal dominant inherited centranuclear myopathy. Zhong Hua Yi Xue Za Zhi 10:663–666 (in Chinese)
10. Liang D (2008) Clinical, pathological and molecular biological study on autosomal dominant inherited centronuclear myopathy. Dissertation, Shandong University (in Chinese)
11. Yang Y, Wu J, Liu H, Chen X, Wang Y, Zhao M, He X (2013) Two homozygous nonsense mutations of GNPTAB gene in two Chinese families with mucolipidosis II alpha/beta using targeted next-generation sequencing. Genomics 102(3):169–173. doi:10.1016/j.ygeno.2013.06.001
12. Jungbluth H, Wallgren-Pettersson C, Laporte J (2008) Centronuclear (myotubular) myopathy. Orphanet J Rare Dis 3:26. doi:10.1186/1750-1172-3-26
13. Park YE, Choi YC, Bae JS, Lee CH, Kim HS, Shin JH, Kim DS (2014) Clinical and Pathological Features of Korean Patients with DNM2-Related Centronuclear Myopathy. Journal of clinical neurology 10(1):24–31. doi:10.3988/jcn.2014.10.1.24
14. Mori-Yoshimura M, Okuma A, Oya Y, Fujimura-Kiyono C, Nakajima H, Matsuura K, Takemura A, Malicdan MC, Hayashi YK, Nonaka I, Murata M, Nishino I (2012) Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2. Clin Neurol Neurosurg 114(6):678–683. doi:10.1016/j.clineuro.2011.10.040
15. Melberg A, Kretz C, Kalimo H, Wallgren-Pettersson C, Toussaint A, Bohm J, Stalberg E, Laporte J (2010) Adult course in dynamin 2 dominant centronuclear myopathy with neonatal onset. Neuromuscul Disord 20(1):53–56. doi:10.1016/j.nmd.2009.10.006
16. Hanisch F, Muller T, Dietz A, Bitoun M, Kress W, Weis J, Stoltenburg G, Zierz S (2011) Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations. J Neurol 258(6):1085–1090. doi:10.1007/s00415-010-5889-5
17. Romero NB, Bitoun M (2011) Centronuclear myopathies. Seminars in pediatric neurology 18(4):250–256. doi:10.1016/j.spen.2011.10.006
18. Catteruccia M, Fattori F, Codemo V, Ruggiero L, Maggi L, Tasca G, Fiorillo C, Pane M, Berardinelli A, Verardo M, Bragato C, Mora M, Morandi L, Bruno C, Santoro L, Pegoraro E, Mercuri E, Bertini E, D’Amico A (2013) Centronuclear myopathy related to dynamin 2 mutations: clinical, morphological, muscle imaging and genetic features of an Italian cohort. Neuromuscul Disord 23(3):229–238. doi:10.1016/j.nmd.2012.12.009
19. Romero NB (2010) Centronuclear myopathies: a widening concept. Neuromuscul Disord 20(4):223–228. doi:10.1016/j.nmd.2010.01.014